"They are the second best-selling drugs worldwide. Over the past 40 years, the development of better drugs that suppress gastric acid secretion, and inhibitors of proton Bompa (Omeprazole ), have been associated with significant improvement of the upper digestive tract, "say the researchers in the latest edition of the Canadian Medical Association Journal.
The potential would be that the acidity of gastric juice can eliminate bacteria the food we eat. To suppress acid secretion, bacteria that colonize the stomach may be able to reach the respiratory tract and cause infections like pneumonia.
"Given the widespread use of inhibitors of proton pump inhibitors and H2 receptor of histamine (like Zantac), to clarify the potential impact of suppressive therapy of stomach acid on the risk pneumonia is highly relevant to public health, "added the researchers.
Our results suggest that the widespread use of these drugs was associated with an increased risk of pneumonia, so this implication is serious. If we assume that there are 19.7 cases of pneumonia per 1,000 people not receiving antacids and admitted to a hospital and if we also assume that the risk of respiratory disease associated with consumption of the products is 1.22 to 1 27 times more, you can expect between 24 and 25 cases of pneumonia per 1,000 users of these medications, "highlights the Korean scientists.
0 comments:
Post a Comment